Skip to main content
Top
Published in: Tumor Biology 5/2015

01-05-2015 | Research Article

Protein interactions of cortactin in relation to invadopodia formation in metastatic renal clear cell carcinoma

Authors: Hong-Liang Shen, Qing-Jun Liu, Pei-Qian Yang, Ye Tian

Published in: Tumor Biology | Issue 5/2015

Login to get access

Abstract

In the present study, we wanted to examine the predominant factor/s in the initiation of metastasis. We used samples of advanced grades of renal clear cell carcinoma with documented clinical history of vena caval spread as the experimental group. The major rationale for this selection is the fact that renal cell carcinoma metastasize extensively through the inferior vena cava up to the pulmonary bed and often exist as a continuous mass of metastatic tissue. As cortactin plays a significant role in invadopodia formation during initiation of metastasis, in the present study, we tested expression of cortactin and phosphotyr421-cortactin in different grades of renal cell clear carcinoma and examined its property to bind to actin. The findings of the present study suggest that the variations of the local physiological milieu are the driving forces for metastasis by enhancing molecular mechanisms for lamellipodia formation. We conclude that localization of cortactin in cancer cells and interaction between actin and its nucleators are crucial for cancer progression.
Literature
1.
go back to reference McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014;16:717–27.CrossRefPubMed McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014;16:717–27.CrossRefPubMed
3.
go back to reference Scheel C, Weinberg RA. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol. 2012;22:396–403.CrossRefPubMed Scheel C, Weinberg RA. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol. 2012;22:396–403.CrossRefPubMed
5.
go back to reference Nantajit D, Lin D, Li JJ. The network of epithelial-mesenchymal transition: potential new targets for tumor resistance. J Cancer Res Clin Oncol. 2014. Nantajit D, Lin D, Li JJ. The network of epithelial-mesenchymal transition: potential new targets for tumor resistance. J Cancer Res Clin Oncol. 2014.
7.
go back to reference Derynck R, Muthusamy BP, Saeteurn KY. Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition. Curr Opin Cell Biol. 2014;31C:56–66.CrossRef Derynck R, Muthusamy BP, Saeteurn KY. Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition. Curr Opin Cell Biol. 2014;31C:56–66.CrossRef
8.
go back to reference Giarnieri E, Bellipanni G, Macaluso M, Mancini R, Holstein AC, Milanese C, et al. Review: cell dynamics in malignant pleural effusions. J Cell Physiol. 2014. Giarnieri E, Bellipanni G, Macaluso M, Mancini R, Holstein AC, Milanese C, et al. Review: cell dynamics in malignant pleural effusions. J Cell Physiol. 2014.
9.
go back to reference Moyret-Lalle C, Ruiz E, Puisieux A. Epithelial-mesenchymal transition transcription factors and miRNAs: “plastic surgeons” of breast cancer. World J Clin Oncol. 2014;5:311–22.CrossRefPubMedPubMedCentral Moyret-Lalle C, Ruiz E, Puisieux A. Epithelial-mesenchymal transition transcription factors and miRNAs: “plastic surgeons” of breast cancer. World J Clin Oncol. 2014;5:311–22.CrossRefPubMedPubMedCentral
10.
go back to reference O’Connor JW, Gomez EW. Biomechanics of TGFβ-induced epithelial-mesenchymal transition: implications for fibrosis and cancer. Clin Transl Med. 2014;3:23.CrossRefPubMedPubMedCentral O’Connor JW, Gomez EW. Biomechanics of TGFβ-induced epithelial-mesenchymal transition: implications for fibrosis and cancer. Clin Transl Med. 2014;3:23.CrossRefPubMedPubMedCentral
11.
go back to reference Martin TA. The role of tight junctions in cancer metastasis. Semin Cell Dev Biol. 2014. Martin TA. The role of tight junctions in cancer metastasis. Semin Cell Dev Biol. 2014.
12.
go back to reference Wong TS, Gao W, Chan JY. Transcription regulation of E-cadherin by zinc finger E-box binding homeobox proteins in solid tumors. Biomed Res Int. 2014;2014:921564.PubMedPubMedCentral Wong TS, Gao W, Chan JY. Transcription regulation of E-cadherin by zinc finger E-box binding homeobox proteins in solid tumors. Biomed Res Int. 2014;2014:921564.PubMedPubMedCentral
13.
go back to reference Chiodoni C, Colombo MP, Sangaletti S. Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis. Cancer Metastasis Rev. 2010;29:295–307.CrossRefPubMed Chiodoni C, Colombo MP, Sangaletti S. Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis. Cancer Metastasis Rev. 2010;29:295–307.CrossRefPubMed
14.
go back to reference Wells A, Chao YL, Grahovac J, Wu Q, Lauffenburger DA. Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis. Front Biosci (Landmark Ed). 2011;16:815–37.CrossRef Wells A, Chao YL, Grahovac J, Wu Q, Lauffenburger DA. Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis. Front Biosci (Landmark Ed). 2011;16:815–37.CrossRef
15.
go back to reference Conti A, Santoni M, Amantini C, Burattini L, Berardi R, Santoni G, et al. Progress of molecular targeted therapies for advanced renal cell carcinoma. Biomed Res Int. 2013;2013:419176.CrossRefPubMedPubMedCentral Conti A, Santoni M, Amantini C, Burattini L, Berardi R, Santoni G, et al. Progress of molecular targeted therapies for advanced renal cell carcinoma. Biomed Res Int. 2013;2013:419176.CrossRefPubMedPubMedCentral
16.
go back to reference Géraud C, Koch PS, Damm F, Schledzewski K, Goerdt S. The metastatic cycle: metastatic niches and cancer cell dissemination. J Dtsch Dermatol Ges. 2014. Géraud C, Koch PS, Damm F, Schledzewski K, Goerdt S. The metastatic cycle: metastatic niches and cancer cell dissemination. J Dtsch Dermatol Ges. 2014.
17.
go back to reference Khan MI, Czarnecka AM, Duchnowska R, Kukwa W, Szczylik C. Metastasis-initiating cells in renal cancer. Curr Signal Transduct Ther. 2014;8:240–6.CrossRefPubMed Khan MI, Czarnecka AM, Duchnowska R, Kukwa W, Szczylik C. Metastasis-initiating cells in renal cancer. Curr Signal Transduct Ther. 2014;8:240–6.CrossRefPubMed
19.
go back to reference Ouderkirk JL, Krendel M. Non-muscle myosins in tumor progression, cancer cell invasion, and metastasis. Cytoskeleton (Hoboken). 2014;71:447–63.CrossRef Ouderkirk JL, Krendel M. Non-muscle myosins in tumor progression, cancer cell invasion, and metastasis. Cytoskeleton (Hoboken). 2014;71:447–63.CrossRef
21.
go back to reference Chawla A, Mishra D, Bansal R, Chundru M. Rare sites of delayed metastasis in renal cell carcinoma. BMJ Case Rep. 2013;2013. Chawla A, Mishra D, Bansal R, Chundru M. Rare sites of delayed metastasis in renal cell carcinoma. BMJ Case Rep. 2013;2013.
22.
go back to reference Casey RG, Raheem OA, Elmusharaf E, Madhavan P, Tolan M, Lynch TH. Renal cell carcinoma with IVC and atrial thrombus: a single centre’s 10 year surgical experience. Surgeon. 2013;11:295–9.CrossRefPubMed Casey RG, Raheem OA, Elmusharaf E, Madhavan P, Tolan M, Lynch TH. Renal cell carcinoma with IVC and atrial thrombus: a single centre’s 10 year surgical experience. Surgeon. 2013;11:295–9.CrossRefPubMed
23.
go back to reference Abel EJ, Wood CG, Eickstaedt N, Fang JE, Kenney P, Bagrodia A, et al. Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus. J Urol. 2013;190:452–7.CrossRefPubMed Abel EJ, Wood CG, Eickstaedt N, Fang JE, Kenney P, Bagrodia A, et al. Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus. J Urol. 2013;190:452–7.CrossRefPubMed
24.
go back to reference Narumiya S, Tanji M, Ishizaki T. Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 2009;28:65–76.CrossRefPubMed Narumiya S, Tanji M, Ishizaki T. Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 2009;28:65–76.CrossRefPubMed
25.
go back to reference Weed SA, Parsons JT. Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene. 2001;20:6418–34.CrossRefPubMed Weed SA, Parsons JT. Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene. 2001;20:6418–34.CrossRefPubMed
26.
go back to reference Schuuring E. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes—a review. Gene. 1995;159:83–96.CrossRefPubMed Schuuring E. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes—a review. Gene. 1995;159:83–96.CrossRefPubMed
27.
go back to reference Balzer EM, Whipple RA, Thompson K, Boggs AE, Slovic J, Cho EH, et al. c-Src differentially regulates the functions of microtentacles and invadopodia. Oncogene. 2010;29:6402–8.CrossRefPubMedPubMedCentral Balzer EM, Whipple RA, Thompson K, Boggs AE, Slovic J, Cho EH, et al. c-Src differentially regulates the functions of microtentacles and invadopodia. Oncogene. 2010;29:6402–8.CrossRefPubMedPubMedCentral
28.
go back to reference Faragalla H, Al-Haddad S, Stewart R, Yousef GM. The significance of florid giant cell component in renal cell carcinoma: a case report and review of the literature. Can J Urol. 2010;17:5219–22.PubMed Faragalla H, Al-Haddad S, Stewart R, Yousef GM. The significance of florid giant cell component in renal cell carcinoma: a case report and review of the literature. Can J Urol. 2010;17:5219–22.PubMed
29.
go back to reference Macdonald A, Horwitz AR, Lauffenburger DA. Kinetic model for lamellipodal actin-integrin ‘clutch’ dynamics. Cell Adhes Migr. 2008;2:95–105.CrossRef Macdonald A, Horwitz AR, Lauffenburger DA. Kinetic model for lamellipodal actin-integrin ‘clutch’ dynamics. Cell Adhes Migr. 2008;2:95–105.CrossRef
30.
go back to reference Eke I, Deuse Y, Hehlgans S, Gurtner K, Krause M, Baumann M, et al. β1 integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. J Clin Invest. 2012;122:1529–40.CrossRefPubMedPubMedCentral Eke I, Deuse Y, Hehlgans S, Gurtner K, Krause M, Baumann M, et al. β1 integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. J Clin Invest. 2012;122:1529–40.CrossRefPubMedPubMedCentral
31.
go back to reference Zhang K, Wang D, Song J. Cortactin is involved in transforming growth factor-beta1-induced epithelial-mesenchymal transition in AML-12 cells. Acta Biochim Biophys Sin (Shanghai). 2009;41:839–45.CrossRef Zhang K, Wang D, Song J. Cortactin is involved in transforming growth factor-beta1-induced epithelial-mesenchymal transition in AML-12 cells. Acta Biochim Biophys Sin (Shanghai). 2009;41:839–45.CrossRef
32.
go back to reference Boguslavsky S, Grosheva I, Landau E, Shtutman M, Cohen M, Arnold K, et al. p120 catenin regulates lamellipodial dynamics and cell adhesion in cooperation with cortactin. Proc Natl Acad Sci U S A. 2007;104:10882–7.CrossRefPubMedPubMedCentral Boguslavsky S, Grosheva I, Landau E, Shtutman M, Cohen M, Arnold K, et al. p120 catenin regulates lamellipodial dynamics and cell adhesion in cooperation with cortactin. Proc Natl Acad Sci U S A. 2007;104:10882–7.CrossRefPubMedPubMedCentral
33.
go back to reference Kirkbride KC, Sung BH, Sinha S, Weaver AM. Cortactin: a multifunctional regulator of cellular invasiveness. Cell Adhes Migr. 2011;5:187–98.CrossRef Kirkbride KC, Sung BH, Sinha S, Weaver AM. Cortactin: a multifunctional regulator of cellular invasiveness. Cell Adhes Migr. 2011;5:187–98.CrossRef
34.
go back to reference Wang GC, Hsieh PS, Hsu HH, Sun GH, Nieh S, Yu CP, et al. Expression of cortactin and survivin in renal cell carcinoma associated with tumor aggressiveness. World J Urol. 2009;27:557–63.CrossRefPubMed Wang GC, Hsieh PS, Hsu HH, Sun GH, Nieh S, Yu CP, et al. Expression of cortactin and survivin in renal cell carcinoma associated with tumor aggressiveness. World J Urol. 2009;27:557–63.CrossRefPubMed
35.
go back to reference Matsuo T, Miyata Y, Watanabe S, Ohba K, Hayashi T, Kanda S, et al. Pathologic significance and prognostic value of phosphorylated cortactin expression in patients with sarcomatoid renal cell carcinoma. Urology. 2011;78(2):476.e9–15.CrossRef Matsuo T, Miyata Y, Watanabe S, Ohba K, Hayashi T, Kanda S, et al. Pathologic significance and prognostic value of phosphorylated cortactin expression in patients with sarcomatoid renal cell carcinoma. Urology. 2011;78(2):476.e9–15.CrossRef
36.
go back to reference Zhang Y, Zhang M, Dong H, Yong S, Li X, Olashaw N, et al. Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene. 2009;28(3):445–60.CrossRefPubMed Zhang Y, Zhang M, Dong H, Yong S, Li X, Olashaw N, et al. Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene. 2009;28(3):445–60.CrossRefPubMed
Metadata
Title
Protein interactions of cortactin in relation to invadopodia formation in metastatic renal clear cell carcinoma
Authors
Hong-Liang Shen
Qing-Jun Liu
Pei-Qian Yang
Ye Tian
Publication date
01-05-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 5/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2976-8

Other articles of this Issue 5/2015

Tumor Biology 5/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine